selected scholarly activity
-
chapters
- Rare Tumours of the Central Nervous System in Childhood. 303-316. 2024
- Genetics of Cerebellar Low-Grade Astrocytomas. 431-446. 2015
- Pediatric Neuro-oncology. ix. 2015
- Rare Tumours of the Central Nervous System in Children. 185-194. 2015
-
conferences
- EPCT-12. NATIONAL MULTICENTERED RETROSPECTIVE REVIEW OF DEMOGRAPHIC, TUMOUR AND INTRAOPERATIVE FEATURES ASSOCIATED WITH THE DEVELOPMENT OF CEREBELLAR MUTISM AFTER PEDIATRIC POSTERIOR FOSSA TUMOUR RESECTION. Neuro-Oncology. i49-i49. 2021
- QOL-02. PERCEPTIONS OF LATE EFFECTS CARE NEEDS AMONG SURVIVORS OF PEDIATRIC BRAIN TUMOURS. Neuro-Oncology. iii431-iii431. 2020
- QOL-46. LATE EFFECTS CARE FOR CHILDHOOD BRAIN TUMOUR SURVIVORS: A QUALITY IMPROVEMENT PROJECT. Neuro-Oncology. iii439-iii439. 2020
- DISSECTING REGULATORS OF THE ABERRANT POST-TRANSCRIPTIONAL LANDSCAPE IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA. Neuro-Oncology. 399-399. 2020
- PERCEPTIONS OF LATE EFFECTS CARE NEEDS AMONG SURVIVORS OF PEDIATRIC BRAIN TUMOURS. Neuro-Oncology. 431-431. 2020
- Performance of an Ehealth Decision Support Tool (MIPOGG) for Identifying Children With Constitutional Mismatch Repair Deficiency, DICER1 Syndrome, Gorlin Syndrome and Li-Fraumeni Syndrome. Pediatric Blood and Cancer. S218-S218. 2020
- MUSAShi-1 IS A MASTER REGULATOR OF ABERRANT TRANSLATION IN GROUP 3 MEDULLOBLASTOMA. Neuro-Oncology. 112-112. 2019
- A case of epithelioid glioblastoma; unusual presentation of a rare tumour with full biomarker assessment. Brain Pathology. 143-143. 2019
- Abstract 148: Canonical Wnt activation as a therapeutic strategy in pediatric medulloblastoma. Cancer Research. 148-148. 2018
- INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI 1 IN PEDIATRIC GROUP 3 MEDULLOBLASTOMA. Neuro-Oncology. 133-133. 2018
- SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE. Neuro-Oncology. 119-119. 2018
- A SINGLE CENTER RESTROSPECTIVE REVIEW OF RECURRENT OR TREATMENT REFRACTORY PEDIATRIC MEDULLOBLASTOMA. Neuro-Oncology. 72-72. 2017
- Adiposity and depressive symptoms in survivors of childhood brain tumors: A report from the Canadian study of the determinants of endometabolic health in children. Journal of the Neurological Sciences. 746-746. 2017
- Where have all the Fat Cells Gone? A Comparative Analysis of Adiposity Patterns in Paediatric Brian Tumour Patients and Non-Cancer Controls. Pediatric Blood and Cancer. S77-S77. 2016
- ATYPICAL TERATOID RHABDOID TUMORS IN THE FIRST YEAR OF LIFE: SHOULD WE TREAT?. Neuro-Oncology. 1-1. 2016
- DOES DIAGNOSTIC DELAY AFFECT MORBIDITY IN CHILDREN DIAGNOSED WITH BRAIN TUMOURS?. Neuro-Oncology. 40-40. 2016
- MRI AND SURGICAL PARAMETERS TO DETERMINE THE RISK OF A CEREBELLAR MUTISM. Neuro-Oncology. 16-16. 2016
- Children with Brain Tumors have Enhanced Visceral Adiposity Compared to Non-Cancer Controls: A Preliminary Analysis from the Canadian Study of Determinants of Endometabolic Health in Children Study. Hormone Research in Paediatrics. 523-523. 2016
- THE EFFECTIVENESS OF LIFESTYLE INTERVENTION, PHARMACOTHERAPY OR BARIATRIC SURGERY ON LOWERING BMI Z-SCORE IN OBESE SURVIVORS OF CHILDHOOD BRAIN TUMORS: A SYSTEMATIC REVIEW. Pediatric Blood and Cancer. S282-S282. 2015
- NEUROCOGNITIVE EVALUATION OF LONG TERM SURVIVORS WITH ATYPICAL TERATOID RHABDOID TUMOR (ATRT): THE CANADIAN REGISTRY EXPERIENCE. Pediatric Blood and Cancer. S281-S282. 2014
- EPIDEMIOLOGY OF MALIGNANT PONTINE GLIOMAS (MPG) IN THE PAEDIATRIC POPULATION IN CANADA: A STUDY OF THE CANADIAN PAEDIATRIC BRAIN TUMOUR CONSORTIUM (CPBTC). Neuro-Oncology. 58-58. 2014
- NEUROCOGNITIVE EVALUATION OF LONG TERM SURVIVOR'S WITH ATYPICAL TERATOID/RHABDOID TUMOR (ATRT): THE CANADIAN REGISTRY EXPERIENCE. Neuro-Oncology. 2-2. 2014
- SURVIVAL OF CHILDREN WITH MEDULLOBLASTOMA IN CANADA DIAGNOSED BETWEEN 1990 AND 2010. Pediatric Blood and Cancer. S93-S93. 2014
- THE PATHOLOGY OF PEDIATRIC MEDULLOBLASTOMA IN CANADA: RESULTS OF A 20 YEAR EPIDEMIOLOGY STUDY. Pediatric Blood and Cancer. S65-S65. 2014
- INCIDENCE OF MEDULLOBLASTOMA IN CANADIAN CHILDREN. Pediatric Blood and Cancer. S78-S78. 2013
- HIGH-GRADE PAPILLARY TUMOUR OF THE PINEAL REGION IN A YOUNG CHILD WITH LEPTOMENINGEAL DISEASE. Neuro-Oncology. 156-156. 2012
- INCIDENCE OF MEDULLOBLASTOMA IN CANADIAN CHILDREN. Neuro-Oncology. 46-46. 2012
- RECURRENT ANAPLASTIC EPENDYMOMA WITH EXTRACRANIAL METASTASES - TREATMENT WITH SURGERY, RADIATION AND ORAL CHEMOTHERAPY. Neuro-Oncology. 41-42. 2012
- PROGNOSTIC FACTORS INFLUENCING SURVIVAL FOR CNS ATYPICAL TERATOID RHABDOID TUMORS IN BRITISH COLUMBIA. Pediatric Blood and Cancer. 922-922. 2010
- CLAUDIN-6 AND INI-1 IMMUNOHISTOCHEMICAL EXPRESSION IN ATYPICAL TERATOID RHABDOID TUMOURS OF THE CNS. Neuro-Oncology. II64-II64. 2010
- REDEFINING THE INCIDENCE AND OUTCOMES OF CNS ATYPICAL TERATOID RHABDOID TUMOURS AT BC CHILDREN'S HOSPITAL. Pediatric Blood and Cancer. 846-846. 2010
- REDEFINING THE INCIDENCE, OUTCOMES, AND PROGNOSTIC FACTORS FOR CNS ATYPICAL TERATOID RHABDOID TUMOURS AT BC CHILDREN'S HOSPITAL. Neuro-Oncology. II65-II65. 2010
- Atypical Teratoid Rhabdoid Tumours at British Columbia Children's Hospital: "Cryptic cases" and Long-Term Survivors. Journal of Neuropathology and Experimental Neurology. 545-546. 2010
- A new model for predicting venesection therapy requirements in hereditary hemochromatosis using non-invasive liver iron concentration measurement. Blood. 1002A-1002A. 2005
- Optical spectroscopy of single-molecule and aggregate hexabenzocoronene derivatives. Proceedings of SPIE - The International Society for Optical Engineering. 685-695. 2003
- Fc-γ Receptor Cross-Linking by Immune Complexes Induces Matrix Metalloproteinase-1 in U937 Cells via Mitogen-Activated Protein Kinase. Arteriosclerosis, Thrombosis and Vascular Biology. 2533-2538. 2000
- LDL-containing immune complexes induce macrophage matrix metalloproteinase-1 expression via activation of a Fc gamma receptor I-linked mitogen-activated protein kinase pathway. Circulation. 252-252. 1999
- Progress of early action activities at the Blackbird Mine Site. TAILINGS AND MINE WASTE '96. 583-589. 1996
-
journal articles
- Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas. Current Oncology. 31:4022-4029. 2024
- Tubular Injury Biomarkers to Predict CKD and Hypertension at 3 Months Post-Cisplatin in Children. Kidney360. 5:821-833. 2024
- National multicentered retrospective review of clinical and intraoperative factors associated with the development of cerebellar mutism after pediatric posterior fossa tumor resection. Child's Nervous System. 40:1339-1347. 2024
- Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin. Pediatric Nephrology. 39:269-282. 2024
- Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes. Journal of Medical Genetics. 60:1218-1223. 2023
- Correction: Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada. British Journal of Cancer. 129:1362-1362. 2023
- Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada. British Journal of Cancer. 129:318-324. 2023
- A single center experience in the management of progressive juvenile pilocytic astrocytoma. Journal of Neurosurgical Sciences. 67:311-316. 2023
- External ventricular drainage in the management of pediatric patients with posterior fossa tumors and hydrocephalus: a retrospective cohort study. Child's Nervous System. 39:887-894. 2023
- Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma. Nature Communications. 14:136. 2023
- Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma. Nature Communications. 13:7506. 2022
- A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL. Brain Tumor Pathology. 39:225-231. 2022
- Late effects care for childhood brain Tumor Survivors: A Quality-Improvement Initiative. Pediatric Hematology and Oncology. 39:291-303. 2022
- Late effects care for childhood brain Tumor Survivors: A Quality-Improvement Initiative.. Pediatric Hematology and Oncology. 39:291-303. 2022
- Characterization of an RNA binding protein interactome reveals the targetable post-transcriptional landscape of MYC-amplified medulloblastoma 2022
- Childhood head trauma and the risk of childhood brain tumours: A case‐control study in Ontario, Canada. International Journal of Cancer. 150:795-801. 2022
- Frosted Branch Angiitis Associated With Cytomegalovirus in a Pediatric Autologous Stem Cell Transplant Patient: Case Report and Review of the Literature. Journal of Pediatric Hematology/Oncology. 44:e479-e481. 2022
- KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors: Description of Clinical Research Protocol of the KINDEST-CCS Study. Canadian Journal of Kidney Health and Disease. 9:205435812211301-205435812211301. 2022
- The Role of a Longitudinal, Multidisciplinary Clinic in Building a Unique Research Collaborative. Frontiers in Oncology. 12:857699. 2022
- Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. JAMA Oncology. 7:1806-1806. 2021
- C.5 Musashi-1 is a master regulator of aberrant translation in MYC-amplified Group 3 medulloblastoma. Canadian Journal of Neurological Sciences. 48:S19-S19. 2021
- Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors. Journal of Clinical Oncology. 39:3207-3216. 2021
- EPCT-12. NATIONAL MULTICENTERED RETROSPECTIVE REVIEW OF DEMOGRAPHIC, TUMOUR AND INTRAOPERATIVE FEATURES ASSOCIATED WITH THE DEVELOPMENT OF CEREBELLAR MUTISM AFTER PEDIATRIC POSTERIOR FOSSA TUMOUR RESECTION. Neuro-Oncology. 23:i49-i49. 2021
- Leptin is Associated with the Tri-Ponderal Mass Index in Children: A Cross-Sectional Study. Adolescent Health, Medicine and Therapeutics. Volume 12:9-15. 2021
- MBRS-01. DISSECTING REGULATORS OF THE ABERRANT POST-TRANSCRIPTIONAL LANDSCAPE IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA. Neuro-Oncology. 22:iii399-iii399. 2020
- MBRS-01. DISSECTING REGULATORS OF THE ABERRANT POST-TRANSCRIPTIONAL LANDSCAPE IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA. Neuro-Oncology. 22:iii399-iii399. 2020
- Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol. Systematic Reviews. 9:47. 2020
- High molecular weight adiponectin levels are inversely associated with adiposity in pediatric brain tumor survivors. Scientific Reports. 10:18606. 2020
- 42 - The Prevalence of Diabetes Mellitus in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis. Canadian Journal of Diabetes. 44:S19-S19. 2020
- Wnt activation as a therapeutic strategy in medulloblastoma. Nature Communications. 11:4323. 2020
- Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC). Journal of Neuro-Oncology. 149:45-54. 2020
- Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy. Journal of Pathology. 251:249-261. 2020
- Myalgia and Hematuria in Association with Clonidine and Arginine Administration for Growth Hormone Stimulation Tests. Case Reports in Medicine. 2020:1-4. 2020
- Circulating leptin levels are associated with adiposity in survivors of childhood brain tumors. Scientific Reports. 10:4711. 2020
- Bariatric interventions in obesity treatment and prevention in pediatric acute lymphoblastic leukemia: a systematic review and meta-analysis. Cancer and Metastasis Reviews. 39:79-90. 2020
- Analysis of factors that influence neurosurgical length of hospital stay among newly diagnosed pediatric brain tumor patients. Pediatric Blood and Cancer. 67:e28041. 2020
- Canadian Pediatric Neuro-Oncology Standards of Practice. Frontiers in Oncology. 10:593192. 2020
- Predictive measures and outcomes of extent of resection in juvenile pilocytic astrocytoma. Journal of Clinical Neuroscience. 70:79-84. 2019
- Salvage Therapy for Childhood Medulloblastoma: A Single Center Experience. Canadian Journal of Neurological Sciences. 46:403-414. 2019
- MEDU-44. MUSASHI-1 IS A MASTER REGULATOR OF ABERRANT TRANSLATION IN GROUP 3 MEDULLOBLASTOMA. Neuro-Oncology. 21:ii112-ii113. 2019
- MEDU-44. MUSASHI-1 IS A MASTER REGULATOR OF ABERRANT TRANSLATION IN GROUP 3 MEDULLOBLASTOMA. Neuro-Oncology. 21:ii112-ii113. 2019
- Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218. Pediatric Blood and Cancer. 66:e27540. 2019
- <p>Evaluating the prevalence of diabetes mellitus subtypes in childhood cancer survivors: a systematic review protocol</p>. Adolescent Health, Medicine and Therapeutics. Volume 10:59-65. 2019
- Tri-ponderal mass index in survivors of childhood brain tumors: A cross-sectional study. Scientific Reports. 8:16336. 2018
- MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE. Neuro-Oncology. 20:i119-i119. 2018
- MBRS-24. INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI 1 IN PEDIATRIC GROUP 3 MEDULLOBLASTOMA. Neuro-Oncology. 20:i133-i133. 2018
- MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE. Neuro-Oncology. 20:i119-i119. 2018
- MBRS-24. INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI 1 IN PEDIATRIC GROUP 3 MEDULLOBLASTOMA. Neuro-Oncology. 20:i133-i133. 2018
- P.044 Salvage therapy in recurrent pediatric medulloblastoma: A single centre experience. Canadian Journal of Neurological Sciences. 45:S27-S27. 2018
- Survival Following Tumor Recurrence in Children With Medulloblastoma. Journal of Pediatric Hematology/Oncology. 40:e159-e163. 2018
- Overweight, obesity and adiposity in survivors of childhood brain tumours: a systematic review and meta‐analysis. Clinical Obesity. 8:55-67. 2018
- Birth weight and body mass index z-score in childhood brain tumors: A cross-sectional study. Scientific Reports. 8:1642. 2018
- Evaluating overweight and obesity prevalence in survivors of childhood brain tumors: a systematic review protocol. Systematic Reviews. 6:43. 2017
- EPID-17. A SINGLE CENTER RESTROSPECTIVE REVIEW OF RECURRENT OR TREATMENT REFRACTORY PEDIATRIC MEDULLOBLASTOMA. Neuro-Oncology. 19:vi72-vi72. 2017
- EPID-17. A SINGLE CENTER RESTROSPECTIVE REVIEW OF RECURRENT OR TREATMENT REFRACTORY PEDIATRIC MEDULLOBLASTOMA. Neuro-Oncology. 19:vi72-vi72. 2017
- Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy. Pediatric Blood and Cancer. 64. 2017
- Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas. Journal of Clinical Oncology. 35:2934-2941. 2017
- The effectiveness of interventions to treat hypothalamic obesity in survivors of childhood brain tumours: a systematic review. Obesity Reviews. 18:899-914. 2017
- Analysis of surgical and MRI factors associated with cerebellar mutism. Journal of Neuro-Oncology. 133:539-552. 2017
- A.03 Analyses of surgical and MRI factors associated with cerebellar mutism. Canadian Journal of Neurological Sciences. 44:S9-S9. 2017
- Adiposity in childhood brain tumors: A report from the Canadian Study of Determinants of Endometabolic Health in Children (CanDECIDE Study). Scientific Reports. 7:45078. 2017
- Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature. Journal of Neuro-Oncology. 132:155-162. 2017
- Progression of atypical extraventricular neurocytoma to anaplastic ganglioglioma. Human Pathology. 59:125-130. 2017
- Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 30:891-908. 2016
- The effectiveness of interventions to treat obesity in survivors of childhood brain tumors: a systematic review protocol. Systematic Reviews. 5:101. 2016
- PS1 - 176 Where Have All the Fat Cells Gone? A Comparative Analysis of Adiposity Patterns in Childhood Brain Tumor Survivors and Non-Cancer Controls. Canadian Journal of Neurological Sciences. 43:S11-S11. 2016
- AT-03ATYPICAL TERATOID RHABDOID TUMORS IN THE FIRST YEAR OF LIFE: SHOULD WE TREAT?. Neuro-Oncology. 18:iii1.2-iii1. 2016
- CMS-02MRI AND SURGICAL PARAMETERS TO DETERMINE THE RISK OF A CEREBELLAR MUTISM. Neuro-Oncology. 18:iii16.2-iii16. 2016
- EPI-04DOES DIAGNOSTIC DELAY AFFECT MORBIDITY IN CHILDREN DIAGNOSED WITH BRAIN TUMOURS?. Neuro-Oncology. 18:iii40.3-iii40. 2016
- CMS-02MRI AND SURGICAL PARAMETERS TO DETERMINE THE RISK OF A CEREBELLAR MUTISM. Neuro-Oncology. 18:iii16-iii16. 2016
- White matter and information processing speed following treatment with cranial-spinal radiation for pediatric brain tumor.. Neuropsychology. 30:425-438. 2016
- Survival of children with medulloblastoma in Canada diagnosed between 1990 and 2009 inclusive. Journal of Neuro-Oncology. 124:247-253. 2015
- Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): The Canadian registry experience. Pediatric Blood and Cancer. 62:1265-1269. 2015
- Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis. The Lancet Oncology. 16:569-582. 2015
- Incidence of medulloblastoma in Canadian children. Journal of Neuro-Oncology. 120:575-579. 2014
- Mapping iron in human heart tissue with synchrotron x-ray fluorescence microscopy and cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 16:80-80. 2014
- Epidemiology of malignant pontine gliomas (MPG) in the paediatric population in Canada: A study of the Canadian paediatric brain tumour consortium (CPBTC). Canadian Journal of Neurological Sciences. 41:S16-S16. 2014
- A novel approach to total skin irradiation using helical TomoTherapy. Practical Radiation Oncology. 4:330-335. 2014
- Exploring the Attitudes of Pediatric Oncologists Toward the Use of Laxatives for the Prevention of Constipation in Patients Undergoing Active Treatment: A Canadian Perspective. Pediatric Hematology and Oncology. 31:448-457. 2014
- Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR. Nature Genetics. 46:39-44. 2014
- Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathologica. 125:659-669. 2013
- Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations. Acta Neuropathologica. 124:615-625. 2012
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma. Cancer Cell. 22:425-437. 2012
- Atypical Teratoid Rhabdoid Tumors (ATRTs): The British Columbia's Children's Hospital's Experience, 1986–2006. Brain Pathology. 22:625-635. 2012
- K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathologica. 124:439-447. 2012
- Brain Tumors in Children. Current Problems in Pediatric and Adolescent Health Care. 42:80-103. 2012
- Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experience. European Journal of Cancer. 48:353-359. 2012
- Calibration of myocardial iron concentration against T2-star Cardiovascular Magnetic Resonance. Journal of Cardiovascular Magnetic Resonance. 11:p224. 2009
- Combined Neutrophil and Erythrocyte Agglutination in a 7-year-old Boy. Journal of Pediatric Hematology/Oncology. 29:664-665. 2007
- A New Model for Predicting Venesection Therapy Requirements in Hereditary Hemochromatosis Using Non-Invasive Liver Iron Concentration Measurement.. Blood. 106:3596-3596. 2005
- Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 105:855-861. 2005
-
preprints